Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Minimed GroupFRA:B8S +4.39%15 Gross Margin % is 57.35% as of Apr. 2026, which is 0% above its 10-year median of 57.22. GuruFocus rates FRA:B8S with a GF Score™ of 15/100. The stock has 3 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Minimed Group ranks worse than 51% on this metric.
The historical rank and industry rank for Minimed Group's Gross Margin % or its related term are showing as below:
FRA:B8S'
s Gross Margin % Range Over the Past 10 Years
Min: 51.75 Med: 57.22 Max: 58.26
Current: 51.75
During the past 4 years, the highestGross Margin % of Minimed Group was 58.26%. The lowest was 51.75%. And the median was 57.22%.
FRA:B8S's Gross Margin % is ranked worse than 51% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.26
vs FRA:B8S: 51.75
Minimed Group had a gross margin of 57.35% for the quarter that ended in Apr. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Minimed Group was 0.00% per year.
Minimed Group (FRA:B8S) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Minimed Group had a gross margin of 57.35% for the quarter that ended in Apr. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Minimed Group Gross Margin % Related Terms
Minimed Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Minimed Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:B8S vs MMSI, NVST, STVN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Minimed Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Minimed Group Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Minimed Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Minimed Group (FRA:B8S) has a Gross Margin % of 57.35% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Minimed Group and its competitors. This is near median its historical median of 57.22. Over the past decade, Minimed Group's Gross Margin % has ranged from 51.75 to 58.26. According to the industry distribution chart, Minimed Group ranks #410 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 51%.
Is Minimed Group's Gross Margin % too high?
Minimed Group's current Gross Margin % of 57.35% is near median its 10-year median of 57.22. Over the past 10 years, this metric has ranged from a low of 51.75 to a high of 58.26. The Medical Devices & Instruments industry median Gross Margin % is 52.26. Minimed Group's value of 57.35% is 9.7% above this industry median. Based on the distribution chart, Minimed Group ranks #410 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Gross Margin % compare to MMSI and NVST?
According to the Medical Devices & Instruments industry distribution chart, Minimed Group ranks #410 out of 804 companies for Gross Margin %. This places Minimed Group in the lower half of its industry. The industry median Gross Margin % is 52.26. Minimed Group's value of 57.35% is 9.7% above this benchmark. Historically, Minimed Group's own Gross Margin % has ranged from 51.75 to 58.26 over the past decade. While the company's 10-year median is 57.22 vs. the industry median of 52.26, Minimed Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.26, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Minimed Group's current Gross Margin % of 57.35% is 9.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Minimed Group and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Minimed Group's current Gross Margin % is 57.35%, which is near median its own 10-year median of 57.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (FRA:B8S) has a current Gross Margin % of 57.35%. The current Gross Margin % is 57.35%, which is near median its 10-year median of 57.22 and 9.7% above the Medical Devices & Instruments industry median of 52.26. Minimed Group's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Minimed Group (FRA:B8S), the current Gross Margin % is 57.35% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score
Get the complete analysis for FRA:B8S
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:B8S has been successfully added to your 
